Heart drugs take on warts: new injection shows promise

NCT ID NCT07307131

Completed Disease control Sponsor: Benha University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two different injections for treating skin warts caused by HPV. One group received a mix of furosemide and digoxin (drugs usually used for heart conditions), while the other got polidocanol, a standard treatment. Researchers tracked how well each cleared the warts and checked for side effects and return of warts over 6 months. The trial involved 64 adults with single or multiple warts.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: furosemide and digoxin injection
What this could lead to: If this works, it could offer a new, effective injection treatment for common warts that is safe and has low recurrence.
What could go wrong: This is a small, early-phase trial with only 64 people. The combination drug may cause side effects like pain or swelling, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS WARTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

common wart human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CUTANEOUS WARTS HUMAN PAPILLOMA VIRUS (HPV)

Contacts and locations

Locations

faculty of Medicine

Banhā, Qalyubia Governorate, 13518, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.